公开(公告)号：EP2557933B1

公开(公告)日：2017-10-11

申请号：EP11720151.7

申请日：2011-04-14

申请人： Xeda International

发明人： SARDO, Alberto

IPC分类号： A61K47/26 ,  A61K47/44 ,  A61K36/28 ,  A61K36/61 ,  A61K36/53 ,  A61P33/00 ,  A01N65/00 ,  A61K47/10 ,  A61K47/24 ,  A61K9/08

CPC分类号： A61K47/24 ,  A01N25/02 ,  A01N65/00 ,  A01N65/12 ,  A01N65/28 ,  A61K9/08 ,  A61K31/085 ,  A61K36/28 ,  A61K36/287 ,  A61K36/53 ,  A61K36/61 ,  A61K47/10 ,  A61K47/26 ,  A61K47/44 ,  A61K2300/00 ,  Y02A50/354 ,  A01N25/28 ,  A01N25/30 ,  A01N2300/00

公开(公告)号：EP2654764A1

公开(公告)日：2013-10-30

申请号：EP11808467.2

申请日：2011-12-16

申请人： Ethicon, Inc.

发明人： WANG, Yi-lan ,  MING, Xintian

IPC分类号： A61K36/287 ,  A61P7/04

CPC分类号： A61K36/12 ,  A61K9/0014 ,  A61K36/287 ,  A61K38/39 ,  A61L26/0038 ,  A61L26/0057 ,  A61L2400/04 ,  A61K2300/00

摘要： The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based "Traditional Chinese Medicinal" product and devices incorporating such agents for the delivery thereof to bleeding wounds.

公开(公告)号：EP2278985A4

公开(公告)日：2011-09-07

申请号：EP08874126

申请日：2008-11-06

申请人： AMOREPACIFIC CORP

发明人： PARK JUN SEONG ,  PARK HYE YOON ,  KIM DONG HYUN ,  MOON EUN JEONG ,  CHUNG JI HYE ,  LEE JAE KYOUNG ,  KIM DUCK HEE ,  KIM HAN KON

IPC分类号： A61K36/185

CPC分类号： A61K36/185 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/232 ,  A61K36/28 ,  A61K36/287 ,  A61K36/428 ,  A61K36/45 ,  A61K36/732 ,  A61K36/78 ,  A61K36/8945

摘要： The present invention relates to an extract of a processed herbal medicinal plant and a composition for skin external application which contains the extract. More specifically, the composition for skin external application contains an extract of processed herbal medicinal plant, prepared through a method comprising the steps of: (a) processing an herbal medicinal plant by a process of boiling, steaming, roasting, baking or heating the medicinal plant or a combination of two or more of these processes; (b) obtaining an extract of the processed medicinal plant. The composition shows an improved antioxidant effect.

公开(公告)号：EP1640014A1

公开(公告)日：2006-03-29

申请号：EP04733155.8

申请日：2004-05-14

申请人： TAKARA BIO INC.

发明人： ENOKI, Tatsuji ,  OGAWA, Kinuko ,  OHNOGI, Hiromu ,  SUGIYAMA, Katsumi ,  MURAKI, Nobuko ,  KUDO, Yoko ,  SAGAWA, Hiroaki ,  KATO, Ikunoshin

IPC分类号： A61K36/00 ,  A23L1/30 ,  A23L2/00 ,  A23K1/16 ,  A61P3/10

CPC分类号： A61K36/896 ,  A23K20/10 ,  A23L33/105 ,  A61K36/185 ,  A61K36/28 ,  A61K36/282 ,  A61K36/287 ,  A61K36/70 ,  A61K36/704 ,  A61K36/886 ,  A61K36/906 ,  A61K36/9066

摘要： The present invention relates to a therapeutic agent and prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for an insulin-mimetic action, a food, beverage and feed for treating a preventing a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for enhancing glucose uptake into a cell, and an agent for inducing differentiation into an adipocyte, characterized in that each comprises as an effective ingredient a processed product derived from at least one plant selected from the group consisting of (a) a plant belonging to Tiliaceae, (b) a plant belonging to Zingiberaceae, (c) a plant belonging to Compositae, (d) a plant belonging to Liliaceae, and (e) a plant belonging to Polygonaceae.

摘要翻译： 本发明涉及伴随胰岛素或胰岛素应答异常的疾病的治疗剂和预防剂，胰岛素样作用剂，食品，饮料和饲料，用于治疗伴随异常的疾病的预防 以一定量的胰岛素或胰岛素应答，提供葡萄糖摄取进入细胞的试剂和诱导分化为脂肪细胞的试剂，其特征在于各自包含作为有效成分的来自至少一种植物的加工产物，所述植物选自 （a）属于椴科的植物，（b）属于姜科的植物，（c）属于菊科的植物，（d）属于百合科的植物，和（e）属于蓼科的植物。

公开(公告)号：EP3238732A4

公开(公告)日：2018-07-18

申请号：EP15873562

申请日：2015-12-18

申请人： KOREA INST ORIENTAL MEDICINE

发明人： KIM DONG SEON

IPC分类号： A61K36/28 ,  A23L33/105 ,  A61K36/287 ,  A61K36/54 ,  A61P19/00 ,  A61P19/02 ,  A61P19/06

CPC分类号： A61K36/54 ,  A23L33/105 ,  A61K36/28 ,  A61K36/287 ,  A61K2300/00 ,  A61P19/02 ,  A61P19/06

摘要： An anti-gout composition including the mixed extract of Chrysanthemum indicum and Cinnamomum cassia as an active ingredient shows substantially greater inhibitory effects on xanthine oxidase than when Chrysanthemum indicum or Cinnamomum cassia is used separately. An animal model treated with the mixed extract of Chrysanthemum indicum and Cinnamomum cassia experienced a decrease in uric acid in serum and in urine. The mixed extract of Chrysanthemum indicum and Cinnamomum cassia is an active ingredient induced from a natural material, and, accordingly, the mixed extract is safe and a source material therefor is easily provided. Accordingly, the mixed extract can be widely used in gout-related industries.

公开(公告)号：EP3238732A2

公开(公告)日：2017-11-01

申请号：EP15873562.1

申请日：2015-12-18

申请人： Korea Institute of Oriental Medicine

发明人： KIM, Dong Seon

IPC分类号： A61K36/28 ,  A61K36/54 ,  A61P19/00

CPC分类号： A61K36/54 ,  A23L33/105 ,  A61K36/28 ,  A61K36/287 ,  A61K2300/00 ,  A61P19/02 ,  A61P19/06

摘要： An anti-gout composition including the mixed extract of Chrysanthemum indicum and Cinnamomum cassia as an active ingredient shows substantially greater inhibitory effects on xanthine oxidase than when Chrysanthemum indicum or Cinnamomum cassia is used separately. An animal model treated with the mixed extract of Chrysanthemum indicum and Cinnamomum cassia experienced a decrease in uric acid in serum and in urine. The mixed extract of Chrysanthemum indicum and Cinnamomum cassia is an active ingredient induced from a natural material, and, accordingly, the mixed extract is safe and a source material therefor is easily provided. Accordingly, the mixed extract can be widely used in gout-related industries.

摘要翻译： 包含菊花和桂皮混合提取物作为活性成分的抗痛风组合物对黄嘌呤氧化酶的抑制作用比单独使用菊花或肉桂时表现出更强的抑制作用。 用菊花和肉桂混合提取物处理的动物模型经历了血清和尿中尿酸的降低。 菊花和肉桂的混合提取物是由天然材料诱导的活性成分，因此，混合提取物是安全的，并且容易提供其原料。 因此，混合提取物可广泛用于痛风有关的行业。

公开(公告)号：EP2658522A4

公开(公告)日：2014-12-31

申请号：EP11853614

申请日：2011-12-30

申请人： MARY KAY INC

发明人： FLORENCE TIFFANY ,  HINES MICHELLE ,  GAN DAVID

IPC分类号： A61K36/61 ,  A61K8/97 ,  A61P17/00 ,  A61Q19/00

CPC分类号： A61K8/97 ,  A61K36/28 ,  A61K36/287 ,  A61K36/42 ,  A61K2800/10 ,  A61K2800/5922 ,  A61Q1/02 ,  A61Q17/04 ,  A61Q19/00 ,  A61Q19/004 ,  A61Q19/008 ,  A61Q19/08 ,  A61Q19/10 ,  A61K2300/00

摘要： A method for treating the skin of a subject in need thereof is disclosed. The method includes topically applying to the skin of the subject a cosmetic composition that includes an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract of Silybum marianum and an aqueous, alcoholic, or aqueous-alcoholic extract of Momordica grosvenori fruit.

公开(公告)号：EP2278985B1

公开(公告)日：2014-06-04

申请号：EP08874126.9

申请日：2008-11-06

申请人： Amorepacific Corporation

发明人： PARK, Jun Seong ,  PARK, Hye Yoon ,  KIM, Dong Hyun ,  MOON, Eun Jeong ,  CHUNG, Ji Hye ,  LEE, Jae Kyoung ,  KIM, Duck Hee ,  KIM, Han Kon

IPC分类号： A61K36/185 ,  A61P17/00

CPC分类号： A61K36/185 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/232 ,  A61K36/28 ,  A61K36/287 ,  A61K36/428 ,  A61K36/45 ,  A61K36/732 ,  A61K36/78 ,  A61K36/8945

摘要： The present invention relates to an extract of a processed herbal medicinal plant and a composition for skin external application which contains the extract. More specifically, the composition for skin external application contains an extract of processed herbal medicinal plant, prepared through a method comprising the steps of: (a) processing an herbal medicinal plant by a process of boiling, steaming, roasting, baking or heating the medicinal plant or a combination of two or more of these processes; (b) obtaining an extract of the processed medicinal plant. The composition shows an improved antioxidant effect.

公开(公告)号：EP2647385A4

公开(公告)日：2014-04-30

申请号：EP11845773

申请日：2011-10-28

申请人： MARUZEN PHARMACEUTICALS CO LTD

发明人： OHTO NOBUAKI ,  KISO AKINORI

IPC分类号： A61K36/73 ,  A61K36/00 ,  A61K36/18 ,  A61K36/28 ,  A61P9/00 ,  A61P43/00

CPC分类号： A61K36/185 ,  A61K35/618 ,  A61K36/00 ,  A61K36/16 ,  A61K36/287 ,  A61K36/48 ,  A61K36/53 ,  A61K36/61 ,  A61K36/62 ,  A61K36/67 ,  A61K36/725 ,  A61K36/73 ,  A61K36/734 ,  A61K36/815 ,  A61K36/88 ,  A61K36/9066 ,  A61K2300/00

摘要： To provide a Tie2 activator, a vascular endothelial growth factor (VEGF) inhibitor, an angiogenesis inhibitor, a vascular maturing agent, a vascular normalizing agent and a vascular stabilizing agent, and a pharmaceutical composition having high safety, and an excellent Tie2 activating effect, vascular endothelial growth factor (VEGF) inhibitory effect, angiogenesis inhibitory effect, vascular maturing effect, vascular normalizing effect, and vascular stabilizing effect. A Tie2 activator, a vascular endothelial growth factor (VEGF) inhibitor, an angiogenesis inhibitor, a vascular maturing agent, a vascular normalizing agent and a vascular stabilizing agent, and a pharmaceutical composition containing, as an active ingredient, a hawthorn extract, a starfruit extract, a shellflower extract, a lotus extract, a rooibos extract, an Indian date extract, a Chinese quince extract, a Psidium guava extract, a long pepper extract, a Quillaja extract, a Kouki extract, a ginkgo extract, an oyster extract, a turmeric extract, a chrysanthemum extract, a jujube extract, a Chinese wolfberry extract, a chamomile extract, or a Butcher's Broom extract, or any combination thereof.

公开(公告)号：EP0977556B1

公开(公告)日：2004-09-29

申请号：EP97936084.9

申请日：1997-07-15

申请人： Chen, Sophie

发明人： CHEN, Sophie ,  WANG, Xuhu

IPC分类号： A61K9/14 ,  A61K35/78

CPC分类号： A61K36/287 ,  A61K36/07 ,  A61K36/258 ,  A61K36/315 ,  A61K36/48 ,  A61K36/539 ,  A61K36/889 ,  A61K2300/00

摘要： A composition comprising material from the following herbs: Panax pseudo-ginseng Wall, Isatis Indigotica Fort, Ganoderma lucidum Karst, Dendranthema morifolium Tzvel, Glycyrrhiza glabra L., Scutellaria baicalensis Georgi, Rabdosia rubescens, Serenoa repens. Preferably, the material from each of such herbs is an alcohol extract of dried, cut plants and of the Panax the pseudo-ginseng Wall and each of the other materials are present in a dried, weight-to-weight range of about 1:1-6. The composition is administered orally or by suppository.